These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16790521)

  • 1. Role of platinum-based radio-chemotherapy for locally advanced non-small-cell lung cancer: possible influence of type of platinum on survival data.
    Hotta K; Kiura K
    Ann Oncol; 2006 Nov; 17(11):1724. PubMed ID: 16790521
    [No Abstract]   [Full Text] [Related]  

  • 2. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
    Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
    Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: does cisplatin versus carboplatin make a difference?
    Tiseo M; Boni L; Ardizzoni A
    J Clin Oncol; 2005 Sep; 23(25):6276-7; author reply 6277-8. PubMed ID: 16135504
    [No Abstract]   [Full Text] [Related]  

  • 4. Concurrent daily carboplatin and accelerated hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer.
    Kunitoh H; Watanabe K; Nagatomo A; Okamoto H; Kimbara K
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):103-9. PubMed ID: 9054883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing chemotherapy and radiotherapy in locally advanced non-small cell lung cancer.
    Arriagada R
    Hematol Oncol Clin North Am; 1997 Jun; 11(3):461-72. PubMed ID: 9209906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platinum derivatives alone, a reasonable option to treat locally advanced non-small cell lung cancer with chemo-radiotherapy.
    Sanz Rubiales Á; del Valle Rivero ML; Fiorini Talavera AB; Fernández González M
    Lung Cancer; 2015 Jul; 89(1):84-5. PubMed ID: 25982010
    [No Abstract]   [Full Text] [Related]  

  • 7. Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer.
    Hotta K; Matsuo K; Ueoka H; Kiura K; Tabata M; Tanimoto M
    J Clin Oncol; 2004 Oct; 22(19):3852-9. PubMed ID: 15326195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer].
    Mito A; Yamasaki M; Matsuura K; Kajihara T; Nitta T; Awaya H; Arita K; Kashiwado K; Ohashi N
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1653-6. PubMed ID: 19838022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinums in lung cancer: sufficient or necessary?
    Bunn PA
    J Clin Oncol; 2005 May; 23(13):2882-3. PubMed ID: 15728220
    [No Abstract]   [Full Text] [Related]  

  • 10. Is there a standard regimen for first-line treatment of advanced/metastatic Non-Small-Cell Lung Cancer? What has meta-analyses contributed to today's standard of care.
    Pallis AG; Georgoulias V
    Lung Cancer; 2012 Mar; 75(3):269-74. PubMed ID: 21996086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scheduling of chemotherapy and radiotherapy in locally advanced non-small cell lung cancer.
    Bishop JF
    Lung Cancer; 1995 Jun; 12 Suppl 2():S53-61. PubMed ID: 7551950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin versus carboplatin in NSCLC: is there one "best" answer?
    Sanborn RE
    Curr Treat Options Oncol; 2008 Dec; 9(4-6):326-42. PubMed ID: 19225891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients.
    Aupérin A; Le Péchoux C; Pignon JP; Koning C; Jeremic B; Clamon G; Einhorn L; Ball D; Trovo MG; Groen HJ; Bonner JA; Le Chevalier T; Arriagada R;
    Ann Oncol; 2006 Mar; 17(3):473-83. PubMed ID: 16500915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.
    Chu Q; Vincent M; Logan D; Mackay JA; Evans WK;
    Lung Cancer; 2005 Dec; 50(3):355-74. PubMed ID: 16139391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodality management of regionally advanced non-small-cell lung cancer.
    Belani CP
    Semin Oncol; 1993 Aug; 20(4):302-14. PubMed ID: 8393590
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current data concerning neoadjuvant chemotherapy].
    Depierre A
    Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S11-3. PubMed ID: 16719148
    [No Abstract]   [Full Text] [Related]  

  • 17. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
    Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSCLC: primary tumor size--radiation dose-related accelerated, twice daily radiotherapy by target splitting, preceded by 2 cycles of chemotherapy--first results of a prospective study.
    Wurstbauer K; Deutschmann H; Kopp P; Kranzinger M; Merz F; Nairz O; Studnicka M; Sedlmayer F
    Strahlenther Onkol; 2007 Dec; 183 Spec No 2():38-40. PubMed ID: 18167008
    [No Abstract]   [Full Text] [Related]  

  • 19. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.
    Jiang J; Liang X; Zhou X; Huang R; Chu Z
    Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radio-chemotherapy combination in locally advanced, inoperable, non-small cell bronchial cancers].
    Mornex F
    Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S37-41. PubMed ID: 12538934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.